Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00850655 · ClinicalTrials.gov registry record
Genetic Association Mapping of Malaria Resistance in Anopheles Gambiae
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 20
- Enrollment target
NCT00850655 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 20 participants.
The verdict
NCT00850655 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This is a study of the genetics of malaria transmission by the mosquito vector in Africa, Anopheles gambiae. The study focuses on the mosquito vector, not the human subjects infected with malaria. DNA extracted from infected mosquitoes will be analyzed genetically by microsatellite and single-nucleotide polymorphisms (SNPs) to identify mosquito genes that control mosquito resistance to malaria parasites.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-03 |
| Est. Completion | 2015-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00850655
The ClinicalTrials.gov registry entry for NCT00850655 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00850655 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00850655 about?
NCT00850655 is a clinical study titled "Genetic Association Mapping of Malaria Resistance in Anopheles Gambiae". This is a study of the genetics of malaria transmission by the mosquito vector in Africa, Anopheles gambiae. The study focuses on the mosquito vector, not the human subjects infected with malaria. DNA extracted from infected mosquitoes will be analyzed genetically by microsatellite and single-nucleo...
What is the current status of trial NCT00850655?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2008-03. Estimated completion is 2015-03.
Who is sponsoring clinical trial NCT00850655?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.